Adverse Events
3 stories
-
healthSingle-Fraction SBRT Promising for Prostate Cancer Treatment
Early trial results show single-fraction SBRT effectively controls localized prostate cancer with manageable side effects.
-
healthExtended Steroid Treatment in Atopic Dermatitis Tied to More Health Complications
A German study shows that each additional three months of systemic glucocorticosteroids for atopic dermatitis raises risks for osteoporosis, diabetes, hypertension, and mental health disorders, with duration outweighing total dose.
-
healthUpadacitinib Maintains Safety Across Age Groups in Atopic Dermatitis
Long-term safety data from Phase III studies show upadacitinib is effective for moderate-to-severe atopic dermatitis across age groups, with specific considerations for older adults and higher doses.